Richard A. Zordani Jr., Director at GALECTIN THERAPEUTICS INC (GALT), bought 5,000 shares at $1.61 ($8K) on 2022-04-04, disclosed to the SEC on 2022-04-04.
Open-market purchase of $8k GALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| GALT | BUY | 2024-04-30 | $4K | — | Filing → |
| GALT | BUY | 2022-07-29 | $13K | — | Filing → |
| GALT | BUY | 2022-01-18 | $10K | — | Filing → |